EMEA-001065-PIP01-10
Key facts
| Invented name |
Angiox
|
| Active substance |
Bivalirudin
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0110/2012
|
| PIP number |
EMEA-001065-PIP01-10
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
The Medicines Company UK Limited
|
| Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|